Alpha Crest Capital Management LLC Staar Surgical CO Transaction History

Alpha Crest Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $901,840 - $1.43 Million	12,783 Added 336.39%	16,583 $1.17 Million
Q2 2022 Aug 11, 2022	BUY	$50.24 - $80.48 $190,912 - $305,824	3,800 New	3,800 $270,000
Q1 2022 May 12, 2022	SELL	$57.98 - $93.5 $600,035 - $967,631	-10,349 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$88.02 - $127.79 $770,086 - $1.12 Million	8,749 Added 546.81%	10,349 $945,000
Q3 2021 Nov 10, 2021	SELL	$122.75 - $162.68 $98,200 - $130,144	-800 Reduced 33.33%	1,600 $206,000
Q2 2021 Aug 12, 2021	BUY	$105.76 - $154.96 $253,824 - $371,904	2,400 New	2,400 $366,000
Q2 2020 Aug 12, 2020	SELL	$29.15 - $61.54 $261,971 - $553,059	-8,987 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$25.01 - $42.4 $430,172 - $729,280	-17,200 Reduced 65.68%	8,987 $290,000
Q4 2019 Feb 12, 2020	SELL	$24.55 - $38.13 $56,784 - $88,194	-2,313 Reduced 8.12%	26,187 $921,000
Q3 2019 Nov 12, 2019	BUY	$25.78 - $34.8 $734,730 - $991,799	28,500 New	28,500 $735,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.